Skip to content
Press Release
FEATURED | September 11, 2025

Jason Chambers Headlines the Melanoma Research Fou...

Superyacht Captain, TV Personality, Melanoma Patient and Advocate Poised to Emcee Event Honoring the Melanoma Community  New York City, NY (September 11, 2025) – The...

4 Minute Read
December 23, 2022

Pilot Trial of Tumor Infiltrating Lymphocytes for ...

Melanoma brain metastases (MBM) are a leading cause of morbidity and mortality for patients with advanced disease. Modern systemic therapies do not adequately control brain...

2 Minute Read
December 23, 2022

Identification of angiopoietin-2/Tie signaling mol...

Description: Although immune checkpoint inhibitors (ICI) such as programmed death-1 (PD-1) blockade have made meaningful advances in the treatment of melanoma, drug resista...

2 Minute Read
December 19, 2022

Exploiting Metabolic Vulnerabilities of Macrophage...

While significant progress has been made in developing new therapeutics to control melanoma, the promising clinical outcomes of immune checkpoint inhibitors have drasticall...

2 Minute Read
December 19, 2022

Targeting Melanoma-Intrinsic STING signaling to Re...

Adoptive cell therapy (ACT) using naturally occurring tumor-infiltrating lymphocytes (TIL) can mediate durable tumor regressions and, in some cases, cure in patients with m...

2 Minute Read
December 19, 2022

Regulation of Immunotherapy Resistance in CDKN2A-l...

About 40% of melanoma patients have decreased p16, a tumor suppressor protein that inhibits cell proliferation. However, our laboratory and others have found that p16 can r...

2 Minute Read
December 19, 2022

Role of Core Fucosylation in the Resistance to Imm...

Despite recent therapeutic advances, melanoma remains a major burden that is expected to rise faster than any other cancer in the coming decades. Surgery is frequently cura...

3 Minute Read
December 19, 2022

Biomarkers to Predict Melanoma Patient Immunothera...

Our immune system operates on a balance of cells that that can destroy infected or cancerous tissue with those that prevent attacking healthy tissue. This equilibrium is af...

2 Minute Read
December 19, 2022

Role of the Gli2 Pathway in Melanoma Immunotherapy...

While immunotherapy has revolutionized the management of advanced melanoma, many patients still do not benefit from this treatment strategy. Indeed, currently available imm...

2 Minute Read
December 19, 2022

Noncanonical Autophagy Inhibition as a New Approac...

Cancer treatment was revolutionized when scientists discovered how to activate a patients’ own immune system to fight tumors. Unfortunately, some patients have tumors tha...

3 Minute Read
December 19, 2022

Chromatin Remodeling Alterations and Consequences ...

Melanoma is the most lethal skin cancer and when detected at an advanced stage in which cells have spread throughout the body (known as metastasis), success of currently av...

2 Minute Read
December 19, 2022

How melanoma patients undergoing treatment at onco...

Dr. Dennis is a cancer epidemiologist whose research focus has been in melanoma for 30 years including trend analyses of SEER data, risk factor analyses, meta-analyses, and...

1 Minute Read
December 23, 2021

Rational approaches to achieving tumor-specific T ...

Medical Student Award – Emily Higgs

1 Minute Read

Oct 04, 2025 ET

Seattle Miles for Melanoma 5K

Oct 05, 2025 ET

Los Angeles Miles for Melanoma 5K

Oct 16, 2025 ET

Ask the Expert: Mucosal Melanoma – Current and Emerging Treatments, Research and Patient Perspectives

Oct 16, 2025 ET

5th Annual #GetNakedJax

Oct 18, 2025 ET

San Diego Miles for Melanoma 5K

Oct 25, 2025 ET

CURE OM Global Science Meeting

Oct 30, 2025 ET

Ask The Expert: Minimal Residual Disease Testing in Melanoma Management

Explore Events